Riken Vitamin Co., Ltd. (TSE:4526) announced a private placement of 10,000 series 1 warrants at a price of ¥1,260 per warrant for gross proceeds of ¥12,600,000 on December 26, 2016. The transaction will include participation from Nomura Securities Co. Ltd., Investment Arm. The warrants are exercisable into 1,000,000 common shares of the company at a minimum exercise price of ¥3,700 per share from January 13, 2017 to January 10, 2020. After January 13, 2017, the exercise price is corrected to the price that corresponds to 91% of the closing share price of the ordinary market transaction of our common stock. The warrants will be issued by third party allocation. The company will bear expenses for various expenses of ¥10,000,000, including expenses of legal fees, warrants evaluation expenses, and other expenses. The allotment date is January 12, 2017. The transaction has been approved by the board of directors of the company.